Amgen Q3 Earnings Preview: Focus on Established Product Revenue Erosion
Investors are preparing for Amgen's (AMGN) third-quarter earnings report, scheduled for release after the market closes on November 3. Analysts are primarily focused on the top-line performance of the company's established product portfolio. There is significant concern regarding ongoing revenue erosion within these legacy products. Market participants will be looking for guidance on how these headwinds might impact overall growth and whether new product pipelines can offset the declining sales from older assets.
Tickers: $AMGN
Topics: earnings anticipation revenue erosion